SCHEMBL20911969

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL22604424	0.90	SRC (0.55)	MAPTKMT2ALMNASRCGABRA2
	SCHEMBL20898225	0.86	SRC (0.50)	MAPTKMT2ALMNASRCHTT
	SCHEMBL30662364	0.86	SRC (0.50)	MAPTKMT2ALMNASRCHTT
	SCHEMBL20911860	0.85	SRC (0.49)	MAPTKMT2ALMNASRCEGFR
	SCHEMBL22604453	0.80	FYN (0.46)	MAPTKMT2ALMNASRCHTT
	SCHEMBL20912011	0.80	SRC (0.51)	MAPTKMT2ALMNASRCEGFR
	SCHEMBL20911641	0.79	SRC (0.48)	MAPTKMT2ALMNASRCEGFR
	SCHEMBL20911861	0.78	SRC (0.45)	MAPTKMT2ALMNASRCALDH1A1
	SCHEMBL22086181	0.77	SRC (0.50)	MAPTKMT2ALMNASRCALDH1A1
	SCHEMBL20911839	0.77	SRC (0.52)	MAPTKMT2ALMNASRCHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.